Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
2 other identifiers
interventional
20
1 country
1
Brief Summary
This study will test whether transcranial direct current stimulation (TDCS) can be used safely in children with schizophrenia and if it can improve memory and attention span or auditory hallucinations in these children, at least temporarily. TDCS has temporarily improved memory and attention span in healthy adults and a similar method called TMS has relieved auditory hallucinations in adults with schizophrenia. For the TDCS procedure, the child sits in a chair and two soft sponge electrodes are placed on the child s forehead and held in place with a soft wrapping. One sponge electrode is placed on an arm. The electrodes are attached to a stimulator with a wire. Children with schizophrenia who meet the following criteria may be eligible for this study:
- Are 10 yrs or older age.
- Are participating in NIH protocol 03-M-0035.
- Are on a stable medication regimen for at least 6 months.
- Have problems with memory and attention span or have auditory hallucinations. Participants are randomly assigned to receive either real or sham TDCS on an inpatient or outpatient basis in 20-minute sessions daily, except weekends, for 10 days. For real TDCS, patients receive stimulation to the front of the brain. For sham stimulation, the children have electrodes placed on the forehead, but no actual stimulation is delivered. In addition to TDCS, patients have the following procedures:
- Checks of blood pressure, pulse and breathing rate before, during and right after each stimulation and again 8 hours later.
- Electrocardiogram (EKG) and electroencephalogram (EEG) before starting stimulation and after completing the 10 days of TDCS.
- Interviews and examinations to check for side effects of TDCS.
- Pen-and-paper or computer tests of learning, attention and memory.
- At the end of the 10 sessions, children who were in the sham TDCS group are offered the same number of sessions of active TDCS.
- Follow-up telephone call 1 month after the end of stimulation to see how the child is doing.
- 1- to 2-day outpatient visit 6 months after the stimulation. This visit includes interviews with the parent and the child, rating of the child s psychiatric symptoms, and pen-and-paper or computer tests of thinking, attention and memory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Sep 2008
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2008
CompletedFirst Submitted
Initial submission to the registry
September 20, 2008
CompletedFirst Posted
Study publicly available on registry
September 23, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2015
CompletedDecember 12, 2019
August 18, 2015
September 20, 2008
December 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
TDCS treatment is safe in childhood onset schizophrenia
Secondary Outcomes (1)
Improvement in cognition and psychosis
Interventions
Eligibility Criteria
You may qualify if:
- COS patients (age 10 and above) recruited and followed under the current protocol 03-M-0035, where subjects have been stable (in the judgment of the investigator) on their medications for 2 months with or without PRN medications but continue to experience either:
- Cognitive difficulties as evidenced by information from parents and teachers, clinical interview, and performance (below average based on published norms for each test) on neurocognitive tests (WMS-III Spatial Span (nonverbal) and WMS-III Letter-Number Sequencing (verbal) attention/vigilance (CPT-IP), and verbal learning (HVLT-R), all sub tests of the NIMH MATRICS battery).
- Significant auditory hallucinations as measured by SAPS (scores above 2) or BPRS (scores above 3).
You may not qualify if:
- Broken or abnormal skin in the area of the electrodes.
- Presence of metal in the cranial cavity.
- Holes in the skull from trauma or surgery.
- Positive pregnancy test.
- Presence of other psychiatric illness (e.g. severe anxiety, OCD etc) unless the patient has been on stable medication for the prior 2 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (4)
Asarnow JR, Ben-Meir S. Children with schizophrenia spectrum and depressive disorders: a comparative study of premorbid adjustment, onset pattern and severity of impairment. J Child Psychol Psychiatry. 1988 Jul;29(4):477-88. doi: 10.1111/j.1469-7610.1988.tb00738.x.
PMID: 3215919BACKGROUNDWatkins JM, Asarnow RF, Tanguay PE. Symptom development in childhood onset schizophrenia. J Child Psychol Psychiatry. 1988 Nov;29(6):865-78. doi: 10.1111/j.1469-7610.1988.tb00759.x.
PMID: 3235494BACKGROUNDRussell AT, Bott L, Sammons C. The phenomenology of schizophrenia occurring in childhood. J Am Acad Child Adolesc Psychiatry. 1989 May;28(3):399-407. doi: 10.1097/00004583-198905000-00017.
PMID: 2738007BACKGROUNDBerman RA, Gotts SJ, McAdams HM, Greenstein D, Lalonde F, Clasen L, Watsky RE, Shora L, Ordonez AE, Raznahan A, Martin A, Gogtay N, Rapoport J. Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia. Brain. 2016 Jan;139(Pt 1):276-91. doi: 10.1093/brain/awv306. Epub 2015 Oct 22.
PMID: 26493637DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nitin Gogtay, M.D.
National Institute of Mental Health (NIMH)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 20, 2008
First Posted
September 23, 2008
Study Start
September 17, 2008
Study Completion
August 18, 2015
Last Updated
December 12, 2019
Record last verified: 2015-08-18